Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:27 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Max India Ltd, a holding company with a market capitalization of ₹1,011 Cr, operates in a sector characterized by volatility and evolving market dynamics. The company has experienced fluctuating revenue trends, with sales reported at ₹212 Cr for FY 2023, down from ₹229 Cr in FY 2022, and further declining to ₹191 Cr in FY 2024. The trailing twelve months (TTM) figure stands at ₹156 Cr, indicating a concerning downward trajectory. Quarterly sales have shown a pattern of inconsistency, with a peak of ₹58 Cr in September 2022, followed by a decline to ₹41 Cr in June 2023 and ₹49 Cr in September 2023. This volatility in revenue raises questions about the sustainability of its business model and market strategy, especially in a competitive landscape where consistent growth is essential for investor confidence.
Profitability and Efficiency Metrics
Max India’s profitability metrics paint a troubling picture. The operating profit margin (OPM) has been consistently negative, with a staggering decline to -76% in the latest quarter, reflecting an alarming inability to control costs relative to sales. The company recorded a net profit of -₹139 Cr for FY 2025, which marks a sharp deterioration from the previous year’s loss of ₹56 Cr. This trend is alarming for investors, especially considering the return on equity (ROE) stands at 30%—an apparent contradiction given the ongoing losses. The interest coverage ratio is also concerning, reported at -12.39x, indicating that the company is struggling to meet its interest obligations. Such metrics suggest that while there may be potential in the underlying assets, operational inefficiencies and escalating costs are severely impacting profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Max India reveals a mixed picture. Total liabilities stood at ₹633 Cr, with borrowings increasing significantly to ₹204 Cr as of September 2025, up from ₹102 Cr in March 2025. This rising debt level could be a red flag for potential investors, especially as the company’s reserves have dwindled to ₹415 Cr from ₹588 Cr in FY 2022. The current ratio is a relatively healthy 2.15, suggesting that the company has sufficient liquidity to cover its short-term obligations. However, the price-to-book value ratio at 2.24x hints at potential overvaluation, especially given the poor profitability metrics. The cash conversion cycle has also deteriorated, now standing at -111 days, indicating challenges in managing working capital efficiently. This combination of factors suggests that while the company has liquidity, its overall financial health may be more fragile than it appears.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Max India Ltd reflects a significant concentration of ownership, with promoters holding 49.59% of the shares. This level of promoter ownership can be a double-edged sword; while it may signal commitment to the company’s long-term vision, it also raises concerns about minority shareholder influence. Foreign institutional investors (FIIs) hold 7.02%, a decline from earlier periods, which may indicate waning confidence in the company’s prospects. Domestic institutional investors (DIIs) are minimal at 1.41%, further suggesting a lack of institutional backing. The number of shareholders has fluctuated, standing at 39,796, which shows some stability but also hints at potential investor caution. This pattern reflects a broader sentiment where retail investors may be hesitant to engage with a company that has shown inconsistent financial performance.
Outlook, Risks, and Final Insight
Looking ahead, Max India faces a complex landscape filled with both opportunities and risks. The significant decline in revenues and profitability raises concerns about the company’s ability to execute its business strategy effectively. Operational inefficiencies and rising debt levels could hinder growth prospects, making it essential for management to implement robust cost-control measures and improve operational efficiencies. On the upside, if the company can stabilize its revenue streams and manage its costs better, there might be room for recovery. However, the risks associated with high borrowing coupled with negative cash flows cannot be overlooked. Investors should remain vigilant and consider the potential for volatility as Max India navigates these challenging waters. The path forward will require not just strategic planning but also a renewed focus on operational execution to regain investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Choice International Ltd | 16,657 Cr. | 748 | 841/438 | 91.9 | 59.5 | 0.00 % | 20.0 % | 19.6 % | 10.0 |
| Abans Holdings Ltd | 1,021 Cr. | 202 | 315/165 | 8.34 | 233 | 0.00 % | 9.71 % | 10.2 % | 2.00 |
| Max India Ltd | 1,004 Cr. | 191 | 312/160 | 89.4 | 0.00 % | 23.6 % | 30.0 % | 10.0 | |
| IDFC Ltd | 17,275 Cr. | 108 | / | 19.9 | 83.6 | 0.93 % | 8.49 % | 8.37 % | 10.0 |
| BF Investment Ltd | 1,544 Cr. | 410 | 754/395 | 18.8 | 1,880 | 0.00 % | 4.62 % | 3.39 % | 5.00 |
| Industry Average | 70,235.29 Cr | 2,091.71 | 31.74 | 1,274.21 | 0.26% | 12.46% | 13.71% | 6.86 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44 | 58 | 43 | 56 | 41 | 49 | 41 | 45 | 26 | 43 | 35 | 42 | 37 |
| Expenses | 45 | 56 | 46 | 55 | 53 | 54 | 58 | 66 | 54 | 64 | 64 | 82 | 65 |
| Operating Profit | -1 | 2 | -3 | 1 | -12 | -5 | -17 | -21 | -28 | -21 | -30 | -41 | -28 |
| OPM % | -3% | 4% | -7% | 2% | -31% | -9% | -43% | -46% | -106% | -49% | -85% | -98% | -76% |
| Other Income | 2 | 3 | 3 | 4 | 6 | 6 | 5 | 5 | 6 | 5 | -8 | 4 | 13 |
| Interest | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 6 |
| Profit before tax | -2 | 2 | -4 | 1 | -10 | -2 | -17 | -20 | -27 | -22 | -44 | -45 | -25 |
| Tax % | 83% | 208% | -93% | 388% | 19% | 160% | 8% | 6% | 0% | 3% | 0% | 2% | 4% |
| Net Profit | -4 | -2 | -0 | -4 | -12 | -5 | -18 | -22 | -27 | -23 | -45 | -46 | -26 |
| EPS in Rs | -0.65 | -0.34 | -0.05 | -0.82 | -2.38 | -0.91 | -3.48 | -4.20 | -5.25 | -4.42 | -8.68 | -8.88 | -4.91 |
Last Updated: August 20, 2025, 7:05 am
Below is a detailed analysis of the quarterly data for Max India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 5.00 Cr..
- For Expenses, as of Jun 2025, the value is 65.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Mar 2025) to 65.00 Cr., marking a decrease of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -28.00 Cr.. The value appears strong and on an upward trend. It has increased from -41.00 Cr. (Mar 2025) to -28.00 Cr., marking an increase of 13.00 Cr..
- For OPM %, as of Jun 2025, the value is -76.00%. The value appears strong and on an upward trend. It has increased from -98.00% (Mar 2025) to -76.00%, marking an increase of 22.00%.
- For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -25.00 Cr.. The value appears strong and on an upward trend. It has increased from -45.00 Cr. (Mar 2025) to -25.00 Cr., marking an increase of 20.00 Cr..
- For Tax %, as of Jun 2025, the value is 4.00%. The value appears to be increasing, which may not be favorable. It has increased from 2.00% (Mar 2025) to 4.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is -26.00 Cr.. The value appears strong and on an upward trend. It has increased from -46.00 Cr. (Mar 2025) to -26.00 Cr., marking an increase of 20.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -4.91. The value appears strong and on an upward trend. It has increased from -8.88 (Mar 2025) to -4.91, marking an increase of 3.97.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:51 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 211 | 121 | 229 | 212 | 191 | 163 | 156 |
| Expenses | 216 | 150 | 232 | 202 | 229 | 264 | 275 |
| Operating Profit | -5 | -29 | -3 | 10 | -38 | -101 | -120 |
| OPM % | -2% | -24% | -1% | 5% | -20% | -62% | -77% |
| Other Income | 277 | 0 | 2 | 1 | 4 | -10 | 14 |
| Interest | 27 | 24 | 10 | 6 | 5 | 8 | 10 |
| Depreciation | 8 | 10 | 7 | 8 | 10 | 19 | 21 |
| Profit before tax | 237 | -64 | -18 | -3 | -49 | -139 | -136 |
| Tax % | 2% | -17% | -11% | 245% | 15% | 1% | |
| Net Profit | 232 | -53 | -16 | -10 | -56 | -140 | -139 |
| EPS in Rs | 29,706.00 | -8.30 | -2.52 | -2.03 | -10.97 | -27.05 | -26.89 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -122.84% | 69.81% | 37.50% | -460.00% | -150.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 192.66% | -32.31% | -497.50% | 310.00% |
Max India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -11% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 40% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -13% |
| Last Year: | -30% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 54 | 54 | 54 | 43 | 43 | 44 | 52 |
| Reserves | 652 | 599 | 588 | 499 | 449 | 315 | 415 |
| Borrowings | 182 | 145 | 61 | 45 | 44 | 102 | 204 |
| Other Liabilities | 136 | 198 | 156 | 166 | 148 | 172 | 167 |
| Total Liabilities | 1,024 | 996 | 858 | 753 | 684 | 633 | 838 |
| Fixed Assets | 144 | 156 | 159 | 159 | 193 | 170 | 166 |
| CWIP | 1 | 0 | 0 | 0 | 10 | 21 | 32 |
| Investments | 414 | 334 | 178 | 83 | 63 | 53 | 59 |
| Other Assets | 465 | 506 | 522 | 511 | 418 | 389 | 581 |
| Total Assets | 1,024 | 996 | 858 | 753 | 684 | 633 | 838 |
Below is a detailed analysis of the balance sheet data for Max India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 315.00 Cr. (Mar 2025) to 415.00 Cr., marking an increase of 100.00 Cr..
- For Borrowings, as of Sep 2025, the value is 204.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 102.00 Cr. (Mar 2025) to 204.00 Cr., marking an increase of 102.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 172.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 838.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 633.00 Cr. (Mar 2025) to 838.00 Cr., marking an increase of 205.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2025) to 166.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 581.00 Cr.. The value appears strong and on an upward trend. It has increased from 389.00 Cr. (Mar 2025) to 581.00 Cr., marking an increase of 192.00 Cr..
- For Total Assets, as of Sep 2025, the value is 838.00 Cr.. The value appears strong and on an upward trend. It has increased from 633.00 Cr. (Mar 2025) to 838.00 Cr., marking an increase of 205.00 Cr..
Notably, the Reserves (415.00 Cr.) exceed the Borrowings (204.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -187.00 | -174.00 | -64.00 | -35.00 | -82.00 | -203.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 24 | 22 | 9 | 5 | 9 | 50 |
| Inventory Days | 1,736 | 6,544 | 385 | 223 | 38 | 186 |
| Days Payable | 154 | 633 | 28 | 48 | 148 | 346 |
| Cash Conversion Cycle | 1,607 | 5,932 | 366 | 180 | -100 | -111 |
| Working Capital Days | 438 | 500 | 343 | 249 | -99 | -93 |
| ROCE % | -4% | -0% | 1% | -8% | -24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -32.50 | -13.08 | -2.18 | -3.35 | -9.88 |
| Diluted EPS (Rs.) | -32.50 | -13.08 | -2.17 | -3.35 | -9.88 |
| Cash EPS (Rs.) | -28.06 | -10.96 | -0.15 | -1.34 | -7.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 82.29 | 114.05 | 125.99 | 118.45 | 121.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 82.29 | 114.05 | 125.99 | 118.45 | 121.44 |
| Revenue From Operations / Share (Rs.) | 33.38 | 40.68 | 46.72 | 42.74 | 22.47 |
| PBDIT / Share (Rs.) | -22.91 | -8.20 | 3.00 | 1.17 | -3.72 |
| PBIT / Share (Rs.) | -27.23 | -10.55 | 1.04 | -0.49 | -5.65 |
| PBT / Share (Rs.) | -31.97 | -11.61 | -0.40 | -3.36 | -11.72 |
| Net Profit / Share (Rs.) | -32.38 | -13.31 | -2.12 | -3.01 | -9.73 |
| NP After MI And SOA / Share (Rs.) | -32.21 | -13.06 | -2.41 | -3.35 | -9.88 |
| PBDIT Margin (%) | -68.63 | -20.15 | 6.43 | 2.74 | -16.54 |
| PBIT Margin (%) | -81.57 | -25.93 | 2.22 | -1.16 | -25.12 |
| PBT Margin (%) | -95.77 | -28.53 | -0.86 | -7.86 | -52.13 |
| Net Profit Margin (%) | -97.01 | -32.71 | -4.53 | -7.04 | -43.31 |
| NP After MI And SOA Margin (%) | -96.49 | -32.10 | -5.16 | -7.84 | -43.94 |
| Return on Networth / Equity (%) | -39.14 | -11.45 | -1.91 | -2.83 | -8.13 |
| Return on Capital Employeed (%) | -25.37 | -8.34 | 0.75 | -0.38 | -3.93 |
| Return On Assets (%) | -22.18 | -8.23 | -1.37 | -2.11 | -5.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.06 | 0.13 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.06 | 0.13 |
| Asset Turnover Ratio (%) | 0.22 | 0.24 | 0.25 | 0.24 | 0.11 |
| Current Ratio (X) | 2.15 | 2.47 | 2.86 | 3.58 | 3.49 |
| Quick Ratio (X) | 2.05 | 2.43 | 2.54 | 2.73 | 2.38 |
| Inventory Turnover Ratio (X) | 12.78 | 0.46 | 0.04 | 0.02 | 0.01 |
| Interest Coverage Ratio (X) | -12.39 | -7.72 | 2.08 | 0.61 | -0.81 |
| Interest Coverage Ratio (Post Tax) (X) | -14.95 | -11.53 | -0.46 | -0.07 | -0.80 |
| Enterprise Value (Cr.) | 694.17 | 645.65 | 281.41 | 408.39 | 411.70 |
| EV / Net Operating Revenue (X) | 4.77 | 3.68 | 1.40 | 1.78 | 3.41 |
| EV / EBITDA (X) | -6.95 | -18.24 | 21.77 | 64.67 | -20.59 |
| MarketCap / Net Operating Revenue (X) | 5.51 | 4.86 | 1.75 | 1.73 | 2.86 |
| Price / BV (X) | 2.24 | 1.73 | 0.64 | 0.62 | 0.52 |
| Price / Net Operating Revenue (X) | 5.51 | 4.86 | 1.75 | 1.73 | 2.86 |
| EarningsYield | -0.17 | -0.06 | -0.02 | -0.04 | -0.15 |
After reviewing the key financial ratios for Max India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -32.50. This value is below the healthy minimum of 5. It has decreased from -13.08 (Mar 24) to -32.50, marking a decrease of 19.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is -32.50. This value is below the healthy minimum of 5. It has decreased from -13.08 (Mar 24) to -32.50, marking a decrease of 19.42.
- For Cash EPS (Rs.), as of Mar 25, the value is -28.06. This value is below the healthy minimum of 3. It has decreased from -10.96 (Mar 24) to -28.06, marking a decrease of 17.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.29. It has decreased from 114.05 (Mar 24) to 82.29, marking a decrease of 31.76.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.29. It has decreased from 114.05 (Mar 24) to 82.29, marking a decrease of 31.76.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.38. It has decreased from 40.68 (Mar 24) to 33.38, marking a decrease of 7.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -22.91. This value is below the healthy minimum of 2. It has decreased from -8.20 (Mar 24) to -22.91, marking a decrease of 14.71.
- For PBIT / Share (Rs.), as of Mar 25, the value is -27.23. This value is below the healthy minimum of 0. It has decreased from -10.55 (Mar 24) to -27.23, marking a decrease of 16.68.
- For PBT / Share (Rs.), as of Mar 25, the value is -31.97. This value is below the healthy minimum of 0. It has decreased from -11.61 (Mar 24) to -31.97, marking a decrease of 20.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -32.38. This value is below the healthy minimum of 2. It has decreased from -13.31 (Mar 24) to -32.38, marking a decrease of 19.07.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -32.21. This value is below the healthy minimum of 2. It has decreased from -13.06 (Mar 24) to -32.21, marking a decrease of 19.15.
- For PBDIT Margin (%), as of Mar 25, the value is -68.63. This value is below the healthy minimum of 10. It has decreased from -20.15 (Mar 24) to -68.63, marking a decrease of 48.48.
- For PBIT Margin (%), as of Mar 25, the value is -81.57. This value is below the healthy minimum of 10. It has decreased from -25.93 (Mar 24) to -81.57, marking a decrease of 55.64.
- For PBT Margin (%), as of Mar 25, the value is -95.77. This value is below the healthy minimum of 10. It has decreased from -28.53 (Mar 24) to -95.77, marking a decrease of 67.24.
- For Net Profit Margin (%), as of Mar 25, the value is -97.01. This value is below the healthy minimum of 5. It has decreased from -32.71 (Mar 24) to -97.01, marking a decrease of 64.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -96.49. This value is below the healthy minimum of 8. It has decreased from -32.10 (Mar 24) to -96.49, marking a decrease of 64.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is -39.14. This value is below the healthy minimum of 15. It has decreased from -11.45 (Mar 24) to -39.14, marking a decrease of 27.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is -25.37. This value is below the healthy minimum of 10. It has decreased from -8.34 (Mar 24) to -25.37, marking a decrease of 17.03.
- For Return On Assets (%), as of Mar 25, the value is -22.18. This value is below the healthy minimum of 5. It has decreased from -8.23 (Mar 24) to -22.18, marking a decrease of 13.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.22. It has decreased from 0.24 (Mar 24) to 0.22, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 2.15, marking a decrease of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 2.05. This value exceeds the healthy maximum of 2. It has decreased from 2.43 (Mar 24) to 2.05, marking a decrease of 0.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.78. This value exceeds the healthy maximum of 8. It has increased from 0.46 (Mar 24) to 12.78, marking an increase of 12.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -12.39. This value is below the healthy minimum of 3. It has decreased from -7.72 (Mar 24) to -12.39, marking a decrease of 4.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -14.95. This value is below the healthy minimum of 3. It has decreased from -11.53 (Mar 24) to -14.95, marking a decrease of 3.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 694.17. It has increased from 645.65 (Mar 24) to 694.17, marking an increase of 48.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.77. This value exceeds the healthy maximum of 3. It has increased from 3.68 (Mar 24) to 4.77, marking an increase of 1.09.
- For EV / EBITDA (X), as of Mar 25, the value is -6.95. This value is below the healthy minimum of 5. It has increased from -18.24 (Mar 24) to -6.95, marking an increase of 11.29.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.51. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.51, marking an increase of 0.65.
- For Price / BV (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.24, marking an increase of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.51. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.51, marking an increase of 0.65.
- For EarningsYield, as of Mar 25, the value is -0.17. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.17, marking a decrease of 0.11.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Max India Ltd:
- Net Profit Margin: -97.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -25.37% (Industry Average ROCE: 12.46%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -39.14% (Industry Average ROE: 13.71%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -14.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 31.74)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -97.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Holding Company | 167, Floor 1, Plot- 167A, Ready Money Mansion, Mumbai Maharashtra 400018 | investorhelpline@maxindia.com http://www.maxindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Analjit Singh | Founder & Chairman |
| Ms. Tara Singh Vachani | Vice Chairperson |
| Mr. Rajit Mehta | Managing Director |
| Mr. Mohit Talwar | Non Executive Director |
| Mr. Pradeep Pant | Independent Director |
| Ms. Sharmila Tagore | Independent Director |
| Dr. Ajit Singh | Independent Director |
| Mr. Niten Malhan | Independent Director |
| Mr. Rohit Kapoor | Independent Director |
FAQ
What is the intrinsic value of Max India Ltd?
Max India Ltd's intrinsic value (as of 13 December 2025) is 328.28 which is 71.87% higher the current market price of 191.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,004 Cr. market cap, FY2025-2026 high/low of 312/160, reserves of ₹415 Cr, and liabilities of 838 Cr.
What is the Market Cap of Max India Ltd?
The Market Cap of Max India Ltd is 1,004 Cr..
What is the current Stock Price of Max India Ltd as on 13 December 2025?
The current stock price of Max India Ltd as on 13 December 2025 is 191.
What is the High / Low of Max India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Max India Ltd stocks is 312/160.
What is the Stock P/E of Max India Ltd?
The Stock P/E of Max India Ltd is .
What is the Book Value of Max India Ltd?
The Book Value of Max India Ltd is 89.4.
What is the Dividend Yield of Max India Ltd?
The Dividend Yield of Max India Ltd is 0.00 %.
What is the ROCE of Max India Ltd?
The ROCE of Max India Ltd is 23.6 %.
What is the ROE of Max India Ltd?
The ROE of Max India Ltd is 30.0 %.
What is the Face Value of Max India Ltd?
The Face Value of Max India Ltd is 10.0.